Literature DB >> 34907755

Selected rare paediatric communication neurological disorders.

Blanka Klimova1, Martin Valis1, Jakub Hort2,3, Kamil Kuca4,5.   

Abstract

The purpose of this review is to discuss rare neurological disorders with respect to communication difficulties typical of children. Firstly, communication disorders with special focus on rare communication neurological disorders are discussed. Secondly, on the basis of literature review, the authors explore clinical studies on the most typical rare children's communication neurological disorders. Thirdly, on the basis of the findings from the clinical studies, they set a few recommendations for their medical therapies and management. The methodology was based on the literature review of research studies exploring the research issue. The findings show that the intervention strategies appear to have positive effects on the improvement of speech and language production among children suffering from Landau-Kleffner syndrome and childhood apraxia of speech. Nevertheless, randomized control trials are needed in order to accelerate and facilitate an early and relevant diagnosis and treatment management. In addition, a multidisciplinary approach seems to be the most appropriate for the accurate diagnosis and comprehensive treatment.

Entities:  

Keywords:  Childhood apraxia of speech; Communication; Landau-Kleffner syndrome; Language; Neurological disorders; Treatment

Year:  2018        PMID: 34907755     DOI: 10.32725/jab.2018.002

Source DB:  PubMed          Journal:  J Appl Biomed        ISSN: 1214-021X            Impact factor:   1.797


  25 in total

Review 1.  Landau-Kleffner syndrome: a rare auditory processing disorder series of cases and review of the literature.

Authors:  Marcela Fandiño; Mary Connolly; Laurie Usher; Sheryl Palm; Frederick K Kozak
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2010-11-12       Impact factor: 1.675

2.  Treating speech subsystems in childhood apraxia of speech with tactual input: the PROMPT approach.

Authors:  Philip S Dale; Deborah A Hayden
Journal:  Am J Speech Lang Pathol       Date:  2013-06-28       Impact factor: 2.408

3.  The Landau-Kleffner syndrome.

Authors:  Frank R Kleffner; William M Landau
Journal:  Epilepsia       Date:  2009-08       Impact factor: 5.864

Review 4.  Rare neurological diseases: a Pandora's box for neurology (an European and Italian perspective).

Authors:  A Federico
Journal:  Rev Neurol (Paris)       Date:  2013-02       Impact factor: 2.607

5.  The socioeconomic impact of narcolepsy.

Authors:  Richard Dodel; Helga Peter; Tobias Walbert; Annika Spottke; Carmen Noelker; Karin Berger; Uwe Siebert; Wolfgang H Oertel; Karl Kesper; Heinrich F Becker; Geert Mayer
Journal:  Sleep       Date:  2004-09-15       Impact factor: 5.849

Review 6.  Multi-Nutrient Dietary Intervention Approach to the Management of Alzheimer's Disease - A Mini-Review.

Authors:  Blanka Klimova; Kamil Kuca
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

7.  Therapeutic horse riding improves cognition, mood arousal, and ambulation in children with dyspraxia.

Authors:  Caren E Hession; Brian Eastwood; David Watterson; Christine M Lehane; Nigel Oxley; Barbara A Murphy
Journal:  J Altern Complement Med       Date:  2013-10-02       Impact factor: 2.579

8.  A pilot study transitioning children onto levetiracetam monotherapy to improve language dysfunction associated with benign rolandic epilepsy.

Authors:  Eric H Kossoff; Jenna G Los; Dana F Boatman
Journal:  Epilepsy Behav       Date:  2007-10-23       Impact factor: 2.937

9.  Rare diseases in ICD11: making rare diseases visible in health information systems through appropriate coding.

Authors:  Ségolène Aymé; Bertrand Bellet; Ana Rath
Journal:  Orphanet J Rare Dis       Date:  2015-03-26       Impact factor: 4.123

Review 10.  Alzheimer's disease and language impairments: social intervention and medical treatment.

Authors:  Blanka Klimova; Petra Maresova; Martin Valis; Jakub Hort; Kamil Kuca
Journal:  Clin Interv Aging       Date:  2015-08-27       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.